GLP1R and Insulin resistance: Activation of TGR5 by BAs stimulates the secretion of PYY and GLP-1 from intestinal L cells via the cAMP signalling pathway, thereby improving insulin resistance (IR) and suppressing appetite, and consequently reducing lipid intake (Wahlström et al., 2016).